Type I interferon (IFN-I) strongly inhibits viral replication and is a crucial factor in control-
IntroductionInterferon is a polypeptide which has strong antiviral capacity. [1][2][3] Mice lacking the type I interferon (IFN-I) receptor are unable to limit widespread dissemination of several mouse pathogenic viruses, 4 which highlights the antiviral activity in vivo. Interferons are produced by a wide variety of cell types that are capable of responding to specific microbial elements (eg, double-and single-stranded RNA or DNA of viral origin) via pattern recognition receptors (PRRs). Some PRRs are widely expressed, whereas others are limited to specific cell populations. For instance, RIG-I, 5,6 TLR3, 7-9 and TLR9 10-13 induce IFN-I in a wide variety of hematopoietic and nonhematopoietic cell types as diverse as macrophages, fibroblasts, 14,15 endothelial cells, hepatocytes, 16-18 microglia, and even neurons. 19 In contrast, interferon-inducing Toll-like receptor 7 (TLR7) has only been reported on murine bone marrow (BM)-derived plasmacytoid dendritic cells. 20,21 Two main pathways have been characterized to induce IFN-I production: one through cytoplasmic PRRs, mainly the helicases RIG-I or MDA-5, 5 and the second through transmembrane PRRs, namely TLR3, TLR4, TLR7, and TLR9. [22][23][24][25] After virus recognition by the cytosolic PRRs or TLRs, Tank-binding kinase 1 (TBK1) is activated and induces phosphorylation of the transcription factors IRF3 and IRF7, which form homo-and heterodimers, and migrate into the nucleus. 26,27 IRF3 homodimers induce IFN- production, but are not essential. In contrast, IRF7 (homo-and heterodimers with IRF3) is essential for the production of IFN-␣ via both cytosolic and transmembrane PRR pathways. 23 While irf3 Ϫ/Ϫ mice are still able to produce IFN-I, mice deficient in IRF7 are severely impaired in the production of IFN-I. Therefore, IRF7 has been assigned the master regulator of interferon. 28,29 Although many nonimmune cells possess the molecular elements that may allow them to produce IFN-I, the extent to which they participate in an effective IFN-I response during viral infection is not clear. In this report, we analyzed the contribution of hematopoietic versus nonhematopoietic cells in the production of IFN-I. As expression of IRF7 is essential for production of IFN-I, we used BM chimeras generated from irf7 Ϫ/Ϫ and wild-type (WT) mice. We found that during systemic viral infections, IFN-I from a BM-derived source was essential for the control of virus replication and inhibition of viral spread to peripheral organs. In addition, hematopoietic cell-derived IFN-I controlled disease onset and the extent of pathology. For personal use only. on April 11, 2019. by guest www.bloodjournal.org From cells at a multiplicity of infection (MOI) of 0.01 and plaqued on Vero cells. Lymphocytic choriomeningitis virus (LCMV) strain WE was originally obtained from F. Lehmann-Grube (Heinrich Pette Institute, Hamburg, Germany) and was propagated in L929 cells. Virus titers were measured usin...